Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8<sup>+</sup> T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy

Oncolytic virotherapy has garnered attention as an antigen-agnostic therapeutic cancer vaccine that induces cancer-specific T cell responses without additional antigen loading. As anticancer immune responses are compromised by a lack of antigenicity and chronic immunosuppressive microenvironments, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yun-Hui Jeon, Namhee Lee, Jiyoon Yoo, Solchan Won, Suk-kyung Shin, Kyu-Hwan Kim, Jun-Gyu Park, Min-Gang Kim, Hang-Rae Kim, Keunhee Oh, Dong-Sup Lee
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2022-03-01
Colecção:Biomedicines
Assuntos:
oncolytic vaccinia virus
cancer antigen-specific T cells
stem-like CD8<sup>+</sup> T cells
lymphoid organs
immune checkpoint blockade
Acesso em linha:https://www.mdpi.com/2227-9059/10/4/805
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados